These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1502010)

  • 1. Valproate hepatotoxicity syndrome: hypotheses of pathogenesis.
    Stephens JR; Levy RH
    Pharm Weekbl Sci; 1992 Jun; 14(3A):118-21. PubMed ID: 1502010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Valproate-associated hepatotoxicity--pathogenesis, clinical aspects, therapy and prevention].
    Siemes H; Nau H
    Klin Padiatr; 1991; 203(6):411-9. PubMed ID: 1758143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproate-associated hepatotoxicity and its biochemical mechanisms.
    Eadie MJ; Hooper WD; Dickinson RG
    Med Toxicol Adverse Drug Exp; 1988; 3(2):85-106. PubMed ID: 3131628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. III. Influence of fasting.
    Löscher W; Wahnschaffe U; Hönack D; Drews E; Nau H
    Epilepsy Res; 1993 Dec; 16(3):183-94. PubMed ID: 8119269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential relationships between transaminase abnormality and valproic acid clearance or serum carnitine concentrations in Japanese epileptic patients.
    Goto S; Seo T; Hagiwara T; Ueda K; Yamauchi T; Nagata S; Ando Y; Ishitsu T; Nakagawa K
    J Pharm Pharmacol; 2008 Feb; 60(2):267-72. PubMed ID: 18237476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carnitine in the treatment of valproic acid-induced toxicity.
    Lheureux PE; Hantson P
    Clin Toxicol (Phila); 2009 Feb; 47(2):101-11. PubMed ID: 19280426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal liver failure in 16 children with valproate therapy.
    Scheffner D; König S; Rauterberg-Ruland I; Kochen W; Hofmann WJ; Unkelbach S
    Epilepsia; 1988; 29(5):530-42. PubMed ID: 3137017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatotoxicity in rat following administration of valproic acid.
    Sugimoto T; Woo M; Nishida N; Takeuchi T; Sakane Y; Kobayashi Y
    Epilepsia; 1987; 28(2):142-6. PubMed ID: 3102219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproate metabolites and hepatotoxicity in an epileptic population.
    Tennison MB; Miles MV; Pollack GM; Thorn MD; Dupuis RE
    Epilepsia; 1988; 29(5):543-7. PubMed ID: 3137018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid and the liver.
    Cotariu D; Zaidman JL
    Clin Chem; 1988 May; 34(5):890-7. PubMed ID: 3131043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic Acid and the Liver Injury in Patients with Epilepsy: An Update.
    Guo HL; Jing X; Sun JY; Hu YH; Xu ZJ; Ni MM; Chen F; Lu XP; Qiu JC; Wang T
    Curr Pharm Des; 2019; 25(3):343-351. PubMed ID: 30931853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Valproic acid-induced idiosyncratic liver injury in 4 cases].
    Xiong H; Liu CT; Zhang YH; Bao XH; Jiang YW; Zhao H; Wu XP; Qin J
    Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):890-4. PubMed ID: 23324142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The high incidence of valproate hepatotoxicity in infants may relate to familial metabolic defects.
    Appleton RE; Farrell K; Applegarth DA; Dimmick JE; Wong LT; Davidson AG
    Can J Neurol Sci; 1990 May; 17(2):145-8. PubMed ID: 2113424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Children versus adults: pharmacokinetic and adverse-effect differences.
    Anderson GD
    Epilepsia; 2002; 43 Suppl 3():53-9. PubMed ID: 12060006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproate hepatotoxicity: a review and report of two instances in adults.
    Dickinson RG; Bassett ML; Searle J; Tyrer JH; Eadie MJ
    Clin Exp Neurol; 1985; 21():79-91. PubMed ID: 3939614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of carnitine supplementation in valproate-induced hyperammonaemia.
    Böhles H; Sewell AC; Wenzel D
    Acta Paediatr; 1996 Apr; 85(4):446-9. PubMed ID: 8740302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal liver failure associated with valproate therapy in a patient with Friedreich's disease: review of valproate hepatotoxicity in adults.
    König SA; Schenk M; Sick C; Holm E; Heubner C; Weiss A; König I; Hehlmann R
    Epilepsia; 1999 Jul; 40(7):1036-40. PubMed ID: 10403231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid induced liver injury: An insight into molecular toxicological mechanism.
    Ezhilarasan D; Mani U
    Environ Toxicol Pharmacol; 2022 Oct; 95():103967. PubMed ID: 36058508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. I. Biochemical, histopathological and pharmacokinetic studies.
    Löscher W; Wahnschaffe U; Hönack D; Wittfoht W; Nau H
    Epilepsy Res; 1992 Dec; 13(3):187-98. PubMed ID: 1493781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between risk factors for valproate hepatotoxicity and altered valproate metabolism.
    Kondo T; Kaneko S; Otani K; Ishida M; Hirano T; Fukushima Y; Muranaka H; Koide N; Yokoyama M
    Epilepsia; 1992; 33(1):172-7. PubMed ID: 1733753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.